What is the difference between an observational trial and an interventional trial? Why do people without Parkinson’s disease need to participate in Parkinson’s disease clinical trials? In an interview with the Michael J. Fox Foundation, Dr. Kathleen Poston answers these questions and more as she discusses what it means to part of clinical research. (Login required to view video) View video
A new Stanford-based center will receive nearly $7.3 million in funding over a five-year period to conduct interdisciplinary research on Alzheimer’s disease and related disorders. Visit the ADRC website
We say out of the mouths of babes when a small child shows an adult’s wisdom and understanding of a situation. This phrase was fitting when Mrs. Kochar’s fifth grade class at Pioneer Elementary School in Union City wrote letters of gratitude to local leaders in neuroscience research and treatment of Parkinson’s disease.
Why participating in research will help speed a cure, sponsored by the Michael J. Fox Foundation for Parkinson’s disease research”, narrated by Dave Iverson
Wednesday, February 17, 2021 at 9am PST. Dr. Poston will be discussing cognitive impairment in Parkinson’s disease on the “Dr. Gilbert Hosts” podcast, sponsored by the American Parkinson Disease Association.
Friday, April 2, 2021 at 10am PST. Dr. Poston will be speaking (over Zoom, details to follow) at the Willow Glen Parkinson’s Support Group.
The Atypical Parkinsonism Symposium Sponsored by the American Parkinson’s Disease Association and Stanford University
“Treatment of and Research on Multiple System Atrophy (MSA)”, Dr. Kathleen Poston
"Treatment and Research: Dementia with Lewy Bodies (DLB)”, Dr. Geoff Kerchner
“Swallowing and Speech in Atypical Parkinsonism Disorders”, Megan DePuy